We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Addex to Present at the Swiss Biotech Day 2024 Geneva, Switzerland, April 19, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric...
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update Top-line data from ADX71149 Phase 2 epilepsy study expected by mid-May 2024Launched Neurosterix with...
Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024 Geneva, Switzerland, April 11, 2024 – Addex Therapeutics (SIX and Nasdaq: ADXN), a...
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders Addex receives CHF5M and 20% share of Neurosterix...
Addex to Present at the Bio-Europe Spring 2024 Conference Geneva, Switzerland, March 14, 2024 – Addex Therapeutics (SIX: ADXN), a clinical-stage pharmaceutical company pioneering allosteric...
Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC. Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, January 31, 2024 – Addex Therapeutics...
Addex to Present at the Swiss Equities Baader Conference Geneva, Switzerland, January 9, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering...
Addex to Present at Biotech Showcase™ 2024 CEO to provide update on allosteric modulator pipeline clinical and preclinical development Geneva, Switzerland, January 5, 2024 - Addex...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 3.02 | 3.02 | 3.02 | 12406 | 3.02 | DE |
4 | 0 | 0 | 3.02 | 3.02 | 3.02 | 13342 | 3.02 | DE |
12 | 0 | 0 | 3.02 | 3.02 | 3.02 | 10876 | 3.02 | DE |
26 | 0 | 0 | 3.02 | 3.02 | 3.02 | 19937 | 3.02 | DE |
52 | 0 | 0 | 3.02 | 3.02 | 3.02 | 17253 | 3.02 | DE |
156 | 0 | 0 | 3.02 | 3.02 | 3.02 | 21117 | 3.02 | DE |
260 | 0 | 0 | 3.02 | 3.02 | 3.02 | 9946 | 3.02 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions